Abstract:The purpose of our study was to evaluate the predictive factors of the presence of invasive carcinoma associated with intraductal papillary mucinous neoplasm (IPMN) of the pancreas on MDCT and MRI.Preoperative MDCT or/and MRI of 27 consecutive patients (19 men, 8 women, mean age 61.3 years) who had undergone surgical resection and had a pathological diagnosis of IPMN were retrospectively assessed. The type of ductal involvement, solid appearance of the lesion, location, tumor size of branch duct type and combined type lesions, maximum diameter of the tumor, caliber of the main pancreatic duct and the extent of the common bile duct dilatation were assessed on CT and MRI and correlated with the pathological findings of the invasive carcinoma. Two abdominal radiologists reviewed all the images, and when discrepancies of the findings were found, the consensus was reached by discussion.Pathological analysis revealed carcinoma in situ in two patients and invasive carcinoma in 19 patients arising from the IPMN. The type of ductal involvement (P = 0.038), a solid mass (P = 0.003) and the common bile duct dilatation ( ≥ 15 mm, P = 0.004) were correlated with the presence of associated invasive carcinoma. For the finding of solid and cystic mass in predicting invasive IPMN, the sensitivity was 66.7% (8/12) and specificity was 100.0% (8/8), and for bile duct diameter ≥ 15 mm, the sensitivity was 47.4% (9/19) and specificity was 100.0% (8/8). However, no association was found between the location of the lesion and associated invasive carcinoma. The caliber of the main pancreatic duct of patients with associated invasive carcinoma was significantly larger than that in the cases without invasive carcinoma (8.07 ± 2.23 mm vs. 4.86 ± 1.86 mm, P = 0.002). When using the main pancreatic duct dilatation ≥ 4 mm as the threshold, the sensitivity and specificity in predicting invasive IPMN were 94.7% (18/19) and 37.5% (3/8), respectively. For the branch duct type and combined type, the size of the tumor with associated invasive carcinoma was significantly larger than these without invasive carcinoma (41.35 ± 12.58) mm vs. (23.76 ± 8.06) mm (P = 0.003). When the maximum diameter was ≥ 40 mm, the sensitivity and specificity in predicting invasive IPMN were 50.0% (6/12) and 87.5% (7/8), respectively.The findings of CT and MRI are helpful to predict invasive carcinoma associated with IPMN, which may play an important role in the preoperative evaluation, surgical planning and predicting the prognosis of IPMN.

MRI evaluation for smal er pancreatic carcinoma with lesion size <3cm

Imaging diagnosis of pancreatic cancer and preoperative imaging evaluation of resectability and staging

Accurate imaging diagnosis and evaluation of pancreatic cancer

Diagnostic value of imaging examinations in pancreatic cystic neoplasm

Evaluation of intraductal papillary mucinous neoplasms of the pancreas on MDCT and MRI]

110 Patients with Adenosquamous Carcinomas of the Pancreas (PASC): Imaging Differentiation of Small (≤ 3 Cm) Versus Large (> 3 Cm) Tumors

Small solid tumors (≤2cm) of the pancreas: Relative accuracy and differentiation of CT and MR imaging

[Evaluation of 2D and 3D MRI Imaging in the Diagnosis of Pancreatic Carcinoma].

[MRI in the Evaluation of Peripancreatic Vessel Invasion and Resectability of Pancreatic Carcinoma].

MRI Appearance of Pancreatic Neuroendocrine Neoplasms Correlation with Pathological Grade:Comparative Study

Clinical signifcance of enhanced MRI in differentiating ben ign and malignant pancreatic neuroendocrine tumors

Pancreatic Cyst Size Measurement on Magnetic Resonance Imaging Compared to Pathology

The value of high-field-strength MRCP in diagnosing intraductal papillary mucinous neoplasms of pancreas

MRI Diagnosis of Pancreatic Neuroendocrine Tumors

MRI Diagnosis of Intraductal Papillary Mucinous Neoplasms of the Pancreas

Screening for pancreatic cancer in high-risk individuals using MRI: optimization of scan techniques to detect small lesions

Establishment of a multi-parameters MRI model for predicting small lymph nodes metastases (<10 mm) in patients with resected pancreatic ductal adenocarcinoma

Evaluation of Chronic Pancreatitis With T<sub>1</sub> MRI: A Preliminary Study

Assessment of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in the Differentiation of Pancreatic Ductal Adenocarcinoma from Other Pancreatic Solid Lesions.

[Comparison of MRI Manifestations and Histopathologic Findings in Pancreatic Head Carcinoma in Vivo Ex Vivo].

MRI Findings of Chronic Pancreatitis Coexisting with Pancreatic Carcinoma